Show results for
Refine by
Patient Enrollment Suppliers Serving Denmark
43 companies found
based inRochester, NEW YORK (USA)
Visaris Americas provides truly digital imaging solutions that incorporate key components to transition facilities from film, computed radiography (CR) and aging digital detectors. The Company’s mission is to deliver the highest quality, and the ...
Visaris360 incorporating an efficient, scalable digital PACS archive, powerful and ergonomic diagnostic radiology workstations and a streamlined and efficient radiology workflow system (RIS) is an integrated suite of radiology workflow tools ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging ...
based inBurton-on-Trent, UNITED KINGDOM
Clinigen Clinical Supplies Management combines market-leading clinical trial supplies like comparator sourcing, packaging and labelling with biological sample management. Part of Clinigen’s global supply chain facility and depot network, we deliver ...
We recognise the packaging and labelling obstacles that you may face during your clinical trials - from time constraints to study changes that cause re-work and waste. On average, 50% of all clinical supplies that are packaged and labelled are never ...
based inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
The TheraBionic P1 produces low levels radiofrequency (RF) electromagnetic fields, which are amplitude-modulated at tumor-specific frequencies. The device is coupled with a spoon-shaped antenna, which is placed in the patient’s mouth, more ...
based inConshohocken, PENNSYLVANIA (USA)
Suvoda is a global clinical trial technology company dedicated to supporting complex studies for life-sustaining therapies.We shape digital experiences that empower you to take command over mission-critical and time-sensitive patient interactions in ...
based inRiga, LATVIA
Longenesis has created an end-to-end environment for biomedical institutions, patient organizations and research partners and sponsors - to communicate directly, enabling both safe data curation and compliant, consent-enabled biomedical data ...
Collect Real World Data and patient outcomes; Longenesis.Engage is a digital patient engagement platform that enables the benefits of digital approach to patient engagement and research execution. Conduct multiple research projects, funnel patient ...
based inWellesley, MASSACHUSETTS (USA)
4G Clinical delivers modern, flexible and validated RTSM and supply forecasting solutions to Pharma. 4G Clinical is driven by a single purpose: bring crucial medicines to those who need them, faster. 4G Clinical believes that the way to accelerate ...
Prancer RTSM Rand-Only offers simplified patient tracking for studies that require randomization where inventory management is not a priority. ...
based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
Oncoral is a novel daily irinotecan chemotherapy in development. Irinotecan chemotherapy has an established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily irinotecan tablet with the potential to offer better ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Graft Versus Host Disease (GvHD) is a potentially lethal complication of hematopoietic cell transplantation (HCT) from a donor. When a patient receives a donor’s stem cells, the transplanted cells may identify the patient’s body as ...
based inNew York, NEW YORK (USA)
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic ...
Patient Cloud is a suite of powerful solutions that makes it simple and engaging for patients to participate in any clinical trial – so your trials are easier, faster, and produce better results. Built into the Medidata Clinical Cloud ...
based inTampa, FLORIDA (USA)
CQ, an enterprise quality and safety management system (EQMS+EHS), helps manufacturers and suppliers. Significantly improve an organization’s culture, collaboration, competency, efficiency, performance and innovation through the digital ...
A real-time view across clinical trial processes for higher-quality trial execution. Enable effective management of clinical trials with centralized data, transparent processes, and compliance with ...
based inCambridge, MASSACHUSETTS (USA)
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against ...
VE416 is an orally administered rationally-defined bacterial consortium candidate being developed for the potential treatment of food allergy. VE416 consists of clonal human commensal bacterial strains selected for their ability to suppress allergic ...
based inCarlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique ...
based inIrvine, CALIFORNIA (USA)
JenaValve is a clinical-stage medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis. JenaValve is passionate ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
In the intricate landscape of biopharmaceuticals, development timing is a critical factor that can significantly impact the success or failure of a drug. Saving time can mean the difference between being first to market for a new drug class or a ...
based inAtlanta, GEORGIA (US) (USA)
eCareMD is a care coordination / care management software platform aimed at healthcare practices, particularly for managing chronic conditions and facilitating various healthcare programs under CMS (Centers for Medicare & Medicaid ...
eCareMD's Behavioral Health Integration Software provides a comprehensive platform for managing both mental and physical patient care outside traditional clinical settings. Designed for healthcare providers participating in the CMS BHI program, it ...
based inCambridge, MASSACHUSETTS (USA)
AOBiome has identified significant therapeutic opportunities caused by the adverse impact of the modern environment on human physiology. The human body relies on a system of multiple microorganisms, chemistries, and pathways which have shaped the ...
We have completed six Phase 2 clinical programs and multiple pre-clinical programs. Over 1,000 patients have been enrolled in our clinical trials since 2016. All of those patients except for 28 in ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have responded ...